PSD psivida limited

The announcement of Dr. Jörg Schreiber's from Roche Diagnostics...

  1. 11,779 Posts.
    lightbulb Created with Sketch. 606
    The announcement of Dr. Jörg Schreiber's from Roche Diagnostics signing up as non-executive director of AION (owned by PSD), seems to have PSD powering along! They must be onto something BIG!

    So what on Earth is Roche working on with PSD? And with the current undisclosed top 5 Pharma (Pfizer possibly?) already working with psd to improve their drugs who knows what names or blockbuster drugs are going to be mentioned next?

    With the big pharmas now heavily involved with PSD to further develop their drugs, the only speculation now is who? (Not how big the partners are!) Sooner or later PSD is going to come out with more big names and big deals in the pipeline.

    I expect the BrachySil partner(s) will come next. Perhaps the China BrachySil partner will be the first big name mentioned due to the short drug trial process there. Then as BioSilicon products become developed with the big pharmas, we can expect more announcements with big names, big drugs and even bigger deals.

    So now with Roche in there with the rest of them, the instos can no longer ignore the big pharma involvement with PSD. When we find out more about the other big pharmas and the blockbuster BioSilicon drugs under development expect $2.00+.

 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.